Literatures

Primary Site >> Colorectal Cancer

Gene >> PDCD1

1.
Journal:	J Clin Invest. 1995 Apr;95(4):1897-905.
Title:	Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.
Author:	Wu, X\|Fan, Z\|Masui, H\|Rosen, N\|Mendelsohn, J
PMID:	7706497

2.
Journal:	PLoS One. 2010 Dec 10;5(12):e14282.
Title:	TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
Author:	Zlobec, Inti\|Karamitopoulou, Eva\|Terracciano, Luigi\|Piscuoglio, Salvatore\|Iezzi, Giandomenica\|Muraro, Manuele Giuseppe\|Spagnoli, Giulio\|Baker, Kristi\|Tzankov, Alexandar\|Lugli, Alessandro
PMID:	21179245

3.
Journal:	J Clin Pathol. 2012 Nov;65(11):996-1002.
Title:	Prognostic impact of beta-2-microglobulin expression in colorectal cancers stratified by mismatch repair status.
Author:	Koelzer, Viktor Hendrik\|Baker, Kristi\|Kassahn, Daniela\|Baumhoer, Daniel\|Zlobec, Inti
PMID:	22859396

4.
Journal:	Cancer Res. 2013 Jun 15;73(12):3591-603.
Title:	Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
Author:	Duraiswamy, Jaikumar\|Kaluza, Karen M\|Freeman, Gordon J\|Coukos, George
PMID:	23633484

5.
Journal:	Med Oncol. 2013 Dec;30(4):743.
Title:	Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B).
Author:	Formica, Vincenzo\|Cereda, Vittore\|di Bari, Maria-Giovana\|Grenga, Italia\|Tesauro, Manfredi\|Raffaele, Palmirotta\|Ferroni, Patrizia\|Guadagni, Fiorella\|Roselli, Mario
PMID:	24114613

6.
Journal:	Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2965-70.
Title:	Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type.
Author:	Gatalica, Zoran\|Snyder, Carrie\|Maney, Todd\|Ghazalpour, Anatole\|Holterman, Daniel A\|Xiao, Nianqing\|Overberg, Peggy\|Rose, Inga\|Basu, Gargi D\|Vranic, Semir\|Lynch, Henry T\|Von Hoff, Daniel D\|Hamid, Omid
PMID:	25392179

7.
Journal:	Clin Cancer Res. 2015 Dec 15;21(24):5543-51.
Title:	Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy.
Author:	Rojas, Juan J\|Sampath, Padma\|Hou, Weizhou\|Thorne, Steve H
PMID:	26187615

8.
Journal:	Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):15408-13.
Title:	STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
Author:	Demaria, Olivier\|De Gassart, Aude\|Coso, Sanja\|Gestermann, Nicolas\|Di Domizio, Jeremy\|Flatz, Lukas\|Gaide, Olivier\|Michielin, Olivier\|Hwu, Patrick\|Petrova, Tatiana V\|Martinon, Fabio\|Modlin, Robert L\|Speiser, Daniel E\|Gilliet, Michel
PMID:	26607445

9.
Journal:	Curr Cancer Drug Targets. 2015;15(8):703-15.
Title:	Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical Practice.
Author:	Maurel, Joan\|Postigo, Antonio
PMID:	26452385

10.
Journal:	Oncoimmunology. 2015 Jun 5;4(7):e1058597.
Title:	Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?
Author:	Kroemer, Guido\|Galluzzi, Lorenzo\|Zitvogel, Laurence\|Fridman, Wolf Herve
PMID:	26140250

11.
Journal:	Oncotarget. 2015 Apr 10;6(10):8261-70.
Title:	Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients.
Author:	Napolitano, Maria\|D'Alterio, Crescenzo\|Cardone, Eleonora\|Trotta, Anna Maria\|Pecori, Biagio\|Rega, Daniela\|Pace, Ugo\|Scala, Dario\|Scognamiglio, Giosue\|Tatangelo, Fabiana\|Cacciapuoti, Carmela\|Pacelli, Roberto\|Delrio, Paolo\|Scala, Stefania
PMID:	25823653

12.
Journal:	Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):E966-72.
Title:	Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK.
Author:	Sagiv-Barfi, Idit\|Kohrt, Holbrook E K\|Czerwinski, Debra K\|Ng, Patrick P\|Chang, Betty Y\|Levy, Ronald
PMID:	25730880

13.
Journal:	J Immunother. 2016 May;39(4):171-80.
Title:	Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
Author:	Liu, Jingwei\|Zhang, Shurong\|Hu, Yuefeng\|Yang, Zhaomin\|Li, Jingpo\|Liu, Xuesong\|Deng, Lijuan\|Wang, Yue\|Zhang, Xiaoyan\|Jiang, Ting\|Lu, Xu
PMID:	27070448

14.
Journal:	Clin Colorectal Cancer. 2016 Dec;15(4):285-291.
Title:	The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
Author:	Toh, James W T\|de Souza, Paul\|Lim, Stephanie H\|Singh, Puneet\|Chua, Wei\|Ng, Weng\|Spring, Kevin J
PMID:	27553906

15.
Journal:	Cancer Res. 2016 Oct 15;76(20):5994-6005.
Title:	Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming.
Author:	Rodriguez-Ruiz, Maria E\|Rodriguez, Inmaculada\|Garasa, Saray\|Barbes, Benigno\|Solorzano, Jose Luis\|Perez-Gracia, Jose Luis\|Labiano, Sara\|Sanmamed, Miguel F\|Azpilikueta, Arantza\|Bolanos, Elixabet\|Sanchez-Paulete, Alfonso R\|Aznar, M Angela\|Rouzaut, Ana\|Schalp
PMID:	27550452

16.
Journal:	Evid Based Complement Alternat Med. 2016;2016:7503726.
Title:	Antitumor Effect of Zhihuang Fuzheng Soft Capsules on Tumor-Bearing Mice.
Author:	Bao, Yanyan\|Pan, Xin\|Jin, Yahong\|Gao, Yingjie\|Cui, Xiaolan
PMID:	27493673

17.
Journal:	Mod Pathol. 2016 Nov;29(11):1433-1442.
Title:	Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma.
Author:	Lee, Lik Hang\|Cavalcanti, Marcela S\|Segal, Neil H\|Hechtman, Jaclyn F\|Weiser, Martin R\|Smith, J Joshua\|Garcia-Aguilar, Julio\|Sadot, Eran\|Ntiamoah, Peter\|Markowitz, Arnold J\|Shike, Moshe\|Stadler, Zsofia K\|Vakiani, Efsevia\|Klimstra, David S\|Shia, Jinru
PMID:	27443512

18.
Journal:	Cancer J. 2016 May-Jun;22(3):190-5.
Title:	Immunotherapy Progress in Mismatch Repair-Deficient Colorectal Cancer and Future Therapeutic Challenges.
Author:	Link, James T\|Overman, Michael James
PMID:	27341597

19.
Journal:	J Cancer Res Clin Oncol. 2016 Aug;142(8):1775-80.
Title:	Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer.
Author:	Yoon, Shinkyo\|Kang, Byung Woog\|Park, Su Yeon\|Kim, Hye Jin\|Park, Jun Seok\|Choi, Gyu Seog\|Kim, Jong Gwang
PMID:	27339628

20.
Journal:	Onco Targets Ther. 2016 Mar 31;9:1899-920.
Title:	Advances in targeted and immunobased therapies for colorectal cancer in the genomic era.
Author:	Seow, Heng Fong\|Yip, Wai Kien\|Fifis, Theodora
PMID:	27099521

21.
Journal:	Clin Cancer Res. 2016 Oct 1;22(19):4827-4836.
Title:	Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes.
Author:	McCann, Katy J\|Mander, Ann\|Cazaly, Angelica\|Chudley, Lindsey\|Stasakova, Jana\|Thirdborough, Stephen\|King, Andrew\|Lloyd-Evans, Paul\|Buxton, Emily\|Edwards, Ceri\|Halford, Sarah\|Bateman, Andrew\|O'Callaghan, Ann\|Clive, Sally\|Anthoney, Alan\|Jodrell, Duncan I\|Wei
PMID:	27091407

22.
Journal:	Eur J Cancer. 2016 May;59:160-170.
Title:	Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives.
Author:	Moehler, Markus\|Delic, Maike\|Goepfert, Katrin\|Aust, Daniela\|Grabsch, Heike I\|Halama, Niels\|Heinrich, Bernd\|Julie, Catherine\|Lordick, Florian\|Lutz, Manfred P\|Mauer, Murielle\|Alsina Maqueda, Maria\|Schild, Hansjoerg\|Schimanski, Carl C\|Wagner, Anna-Dorothea\|R
PMID:	27039171

23.
Journal:	Front Oncol. 2016 Mar 7;6:50.
Title:	Enrichment of Inflammatory IL-17 and TNF-alpha Secreting CD4(+) T Cells within Colorectal Tumors despite the Presence of Elevated CD39(+) T Regulatory Cells and Increased Expression of the Immune Checkpoint Molecule, PD-1.
Author:	Dunne, Margaret R\|Ryan, Ciara\|Nolan, Blathnaid\|Tosetto, Miriam\|Geraghty, Robert\|Winter, Des C\|O'Connell, P Ronan\|Hyland, John M\|Doherty, Glen A\|Sheahan, Kieran\|Ryan, Elizabeth J\|Fletcher, Jean M
PMID:	27014625

24.
Journal:	Mod Pathol. 2016 May;29(5):528-41.
Title:	Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment.
Author:	Friedman, Kenneth\|Brodsky, Alexander S\|Lu, Shaolei\|Wood, Stephanie\|Gill, Anthony J\|Lombardo, Kara\|Yang, Dongfang\|Resnick, Murray B
PMID:	26965581

25.
Journal:	Oncotarget. 2016 Jan 26;7(4):4522-30.
Title:	Identification of TIM3 2'-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy.
Author:	Hervas-Stubbs, Sandra\|Soldevilla, Mario M\|Villanueva, Helena\|Mancheno, Uxua\|Bendandi, Maurizio\|Pastor, Fernando
PMID:	26683225

26.
Journal:	Clin Exp Pharmacol Physiol. 2017 May;44(5):602-604.
Title:	Increased PD-L1 expression in breast and colon cancer stem cells.
Author:	Wu, Yanheng\|Chen, Mingshui\|Wu, Peihong\|Chen, Chen\|Xu, Zhi Ping\|Gu, Wenyi
PMID:	28107571

27.
Journal:	NPJ Precis Oncol. 2017;1.
Title:	Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology.
Author:	Ogino, Shuji\|Jhun, Iny\|Mata, Douglas A\|Soong, Thing Rinda\|Hamada, Tsuyoshi\|Liu, Li\|Nishihara, Reiko\|Giannakis, Marios\|Cao, Yin\|Manson, JoAnn E\|Nowak, Jonathan A\|Chan, Andrew T
PMID:	29552640

28.
Journal:	Klin Onkol. 2017 Winter;30(Supplementum3):62-65.
Title:	[Immunotherapy of Colorectal and Anal Carcinoma].
Author:	Tomasek, J\|Kiss, I
PMID:	29239195

29.
Journal:	Oncoimmunology. 2017 Aug 18;6(9):e1331194.
Title:	PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer.
Author:	Kollmann, Dagmar\|Schweiger, Thomas\|Schwarz, Stefan\|Ignatova, Desislava\|Chang, Yun-Tsan\|Lewik, Gerrit\|Schoppmann, Sebastian F\|Hoetzenecker, Wolfram\|Klepetko, Walter\|Guenova, Emmanuella\|Hoetzenecker, Konrad
PMID:	28932634

30.
Journal:	Brachytherapy. 2017 Nov - Dec;16(6):1246-1251.
Title:	Brachytherapy attains abscopal effects when combined with immunostimulatory monoclonal antibodies.
Author:	Rodriguez-Ruiz, Maria E\|Rodriguez, Inmaculada\|Barbes, Benigno\|Mayorga, Lina\|Sanchez-Paulete, Alfonso Rodriguez\|Ponz-Sarvise, Mariano\|Perez-Gracia, Jose Luis\|Melero, Ignacio
PMID:	28838649

31.
Journal:	Int J Mol Sci. 2017 Jun 21;18(6). pii: ijms18061324.
Title:	Immune Checkpoints as a Target for Colorectal Cancer Treatment.
Author:	Passardi, Alessandro\|Canale, Matteo\|Valgiusti, Martina\|Ulivi, Paola
PMID:	28635639

32.
Journal:	Front Immunol. 2017 May 26;8:619.
Title:	Intratumoral FoxP3(+)Helios(+) Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer.
Author:	Syed Khaja, Azharuddin Sajid\|Toor, Salman M\|El Salhat, Haytham\|Ali, Bassam R\|Elkord, Eyad
PMID:	28603527

33.
Journal:	Nature. 2017 May 25;545(7655):495-499.
Title:	PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.
Author:	Gordon, Sydney R\|Maute, Roy L\|Dulken, Ben W\|Hutter, Gregor\|George, Benson M\|McCracken, Melissa N\|Gupta, Rohit\|Tsai, Jonathan M\|Sinha, Rahul\|Corey, Daniel\|Ring, Aaron M\|Connolly, Andrew J\|Weissman, Irving L
PMID:	28514441

34.
Journal:	Ann Oncol. 2017 Aug 1;28(8):1996-2001.
Title:	Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study.
Author:	Cabel, L\|Riva, F\|Servois, V\|Livartowski, A\|Daniel, C\|Rampanou, A\|Lantz, O\|Romano, E\|Milder, M\|Buecher, B\|Piperno-Neumann, S\|Bernard, V\|Baulande, S\|Bieche, I\|Pierga, J Y\|Proudhon, C\|Bidard, F-C
PMID:	28459943

35.
Journal:	Cancers (Basel). 2017 May 11;9(5). pii: cancers9050050.
Title:	Immunotherapy for Colorectal Cancer.
Author:	Boland, Patrick M\|Ma, Wen Wee
PMID:	28492495

36.
Journal:	Gut. 2017 Aug;66(8):1463-1473.
Title:	Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.
Author:	Masugi, Yohei\|Nishihara, Reiko\|Yang, Juhong\|Mima, Kosuke\|da Silva, Annacarolina\|Shi, Yan\|Inamura, Kentaro\|Cao, Yin\|Song, Mingyang\|Nowak, Jonathan A\|Liao, Xiaoyun\|Nosho, Katsuhiko\|Chan, Andrew T\|Giannakis, Marios\|Bass, Adam J\|Hodi, F Stephen\|Freeman, Gordo
PMID:	27196573

37.
Journal:	Mod Pathol. 2017 Feb;30(2):278-285.
Title:	Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas.
Author:	Inaguma, Shingo\|Lasota, Jerzy\|Wang, Zengfeng\|Felisiak-Golabek, Anna\|Ikeda, Hiroshi\|Miettinen, Markku
PMID:	27813511

38.
Journal:	Curr Med Res Opin. 2017 Apr;33(4):749-759.
Title:	Targeting the PD-1 pathway: a new hope for gastrointestinal cancers.
Author:	Bilgin, Burak\|Sendur, Mehmet A N\|Bulent Akinci, Muhammed\|Sener Dede, Didem\|Yalcin, Bulent
PMID:	28055269

39.
Journal:	J Exp Clin Cancer Res. 2017 Jan 5;36(1):2.
Title:	RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer.
Author:	Zhu, Houbao\|Xu, Wang-Yang\|Hu, Zhiqiang\|Zhang, Hongxin\|Shen, Yan\|Lu, Shunyuan\|Wei, Chaochun\|Wang, Zhu-Gang
PMID:	28057020

40.
Journal:	Oncoimmunology. 2016 Nov 10;6(1):e1257454.
Title:	PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients.
Author:	Goltz, Diane\|Gevensleben, Heidrun\|Dietrich, Jorn\|Dietrich, Dimo
PMID:	28197377

41.
Journal:	J Clin Oncol. 2017 Jun 1;35(16):1836-1844.
Title:	Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
Author:	Hamada, Tsuyoshi\|Cao, Yin\|Qian, Zhi Rong\|Masugi, Yohei\|Nowak, Jonathan A\|Yang, Juhong\|Song, Mingyang\|Mima, Kosuke\|Kosumi, Keisuke\|Liu, Li\|Shi, Yan\|da Silva, Annacarolina\|Gu, Mancang\|Li, Wanwan\|Keum, NaNa\|Zhang, Xuehong\|Wu, Kana\|Meyerhardt, Jeffrey A\|Giova
PMID:	28406723

42.
Journal:	Sci Rep. 2018 Oct 23;8(1):15658.
Title:	Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II-III colorectal cancer.
Author:	Huang, Chih-Yang\|Chiang, Shu-Fen\|Ke, Tao-Wei\|Chen, Tsung-Wei\|You, Ying-Shu\|Chen, William Tzu-Liang\|Chao, K S Clifford
PMID:	30353144

43.
Journal:	J Gastrointest Oncol. 2018 Aug;9(4):610-617.
Title:	Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition.
Author:	Fabrizio, David A\|George, Thomas J Jr\|Dunne, Richard F\|Frampton, Garrett\|Sun, James\|Gowen, Kyle\|Kennedy, Mark\|Greenbowe, Joel\|Schrock, Alexa B\|Hezel, Aram F\|Ross, Jeffrey S\|Stephens, Phillip J\|Ali, Siraj M\|Miller, Vincent A\|Fakih, Marwan\|Klempner, Samuel
PMID:	30151257

44.
Journal:	EBioMedicine. 2018 Sep;35:178-188.
Title:	ITGAE Defines CD8+ Tumor-Infiltrating Lymphocytes Predicting a better Prognostic Survival in Colorectal Cancer.
Author:	Hu, Xiang\|Li, Ya-Qi\|Li, Qing-Guo\|Ma, Yan-Lei\|Peng, Jun-Jie\|Cai, San-Jun
PMID:	30100393

45.
Journal:	Int J Oncol. 2018 Oct;53(4):1469-1480.
Title:	Upregulation of PDL1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300mediated NFkappaB signaling.
Author:	Lucas, Justin\|Hsieh, Tze-Chen\|Halicka, H Dorota\|Darzynkiewicz, Zbigniew\|Wu, Joseph M
PMID:	30066852

46.
Journal:	Pharm Res. 2018 Jul 30;35(9):183.
Title:	(-)-4-O-(4-O-beta-D-glucopyranosylcaffeoyl) Quinic Acid Inhibits the Function of Myeloid-Derived Suppressor Cells to Enhance the Efficacy of Anti-PD1 against Colon Cancer.
Author:	Lin, HongYue\|Wu, YuZhu\|Chen, JinPing\|Huang, ShuRong\|Wang, YangQiang
PMID:	30062658

47.
Journal:	Oncoimmunology. 2018 Mar 26;7(7):e1445949.
Title:	Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis.
Author:	Harjunpaa, Heidi\|Blake, Stephen J\|Ahern, Elizabeth\|Allen, Stacey\|Liu, Jing\|Yan, Juming\|Lutzky, Viviana\|Takeda, Kazuyoshi\|Aguilera, Amy Roman\|Guillerey, Camille\|Mittal, Deepak\|Li, Xian Yang\|Dougall, William C\|Smyth, Mark J\|Teng, Michele W L
PMID:	29900061

48.
Journal:	Oncoimmunology. 2018 Mar 19;7(7):e1442999.
Title:	TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas.
Author:	Hamada, Tsuyoshi\|Soong, Thing Rinda\|Masugi, Yohei\|Kosumi, Keisuke\|Nowak, Jonathan A\|da Silva, Annacarolina\|Mu, Xinmeng Jasmine\|Twombly, Tyler S\|Koh, Hideo\|Yang, Juhong\|Song, Mingyang\|Liu, Li\|Gu, Mancang\|Shi, Yan\|Nosho, Katsuhiko\|Morikawa, Teppei\|Inamura,
PMID:	29900052

49.
Journal:	Oncoimmunology. 2018 Feb 14;7(6):e1431088.
Title:	RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer.
Author:	Ahern, Elizabeth\|Harjunpaa, Heidi\|O'Donnell, Jake S\|Allen, Stacey\|Dougall, William C\|Teng, Michele W L\|Smyth, Mark J
PMID:	29872559

50.
Journal:	Anticancer Res. 2018 Jun;38(6):3367-3373.
Title:	Programmed Cell Death Ligand 1 Expression Is an Independent Prognostic Factor in Colorectal Cancer.
Author:	Enkhbat, Tumenjin\|Nishi, Masaaki\|Takasu, Chie\|Yoshikawa, Kozo\|Jun, Higashijima\|Tokunaga, Takuya\|Kashihara, Hideya\|Ishikawa, Daichi\|Shimada, Mitsuo
PMID:	29848685

51.
Journal:	Oncotarget. 2018 Apr 6;9(26):18510-18517.
Title:	Histogram analysis of ADC in rectal cancer: associations with different histopathological findings including expression of EGFR, Hif1-alpha, VEGF, p53, PD1, and KI 67. A preliminary study.
Author:	Meyer, Hans Jonas\|Hohn, Annekathrin\|Surov, Alexey
PMID:	29719621

52.
Journal:	Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Apr 10;35(2):219-223.
Title:	[Association of programmed cell death 1 (PDCD1) gene polymorphisms with colorectal cancer among Han Chinese population].
Author:	Zhao, Yuancun\|Mao, Zhigang\|Pang, Hua\|Zhao, Xiaohong\|Zhang, Shu\|Gao, Zehua\|Yang, Yiwen\|Fang, Ting\|Ma, Qizhao\|Ma, Xiaodan\|Wang, Yufang\|Zhang, Ji
PMID:	29652996

53.
Journal:	Hum Immunol. 2018 Jun;79(6):446-452.
Title:	CD8(+)CXCR5(+) T cells in tumor-draining lymph nodes are highly activated and predict better prognosis in colorectal cancer.
Author:	E, Jifu\|Yan, Feihu\|Kang, Zhengchun\|Zhu, Liangliang\|Xing, Junjie\|Yu, Enda
PMID:	29544815

54.
Journal:	J Cancer Res Clin Oncol. 2018 Jun;144(6):1005-1014.
Title:	CD274, LAG3, and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer.
Author:	Lee, Soo Jung\|Jun, Sun-Young\|Lee, In Hee\|Kang, Byung Woog\|Park, Su Yeon\|Kim, Hye Jin\|Park, Jun Seok\|Choi, Gyu-Seog\|Yoon, Ghilsuk\|Kim, Jong Gwang
PMID:	29520442

55.
Journal:	Semin Cancer Biol. 2018 Oct;52(Pt 2):189-197.
Title:	Genomics and emerging biomarkers for immunotherapy of colorectal cancer.
Author:	Kather, Jakob Nikolas\|Halama, Niels\|Jaeger, Dirk
PMID:	29501787

56.
Journal:	Expert Opin Biol Ther. 2018 May;18(5):561-573.
Title:	Results and challenges of immune checkpoint inhibitors in colorectal cancer.
Author:	Emambux, Sheik\|Tachon, Gaelle\|Junca, Audelaure\|Tougeron, David
PMID:	29471676

57.
Journal:	Gut. 2018 Jun;67(6):1168-1180.
Title:	Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.
Author:	Ogino, Shuji\|Nowak, Jonathan A\|Hamada, Tsuyoshi\|Phipps, Amanda I\|Peters, Ulrike\|Milner, Danny A Jr\|Giovannucci, Edward L\|Nishihara, Reiko\|Giannakis, Marios\|Garrett, Wendy S\|Song, Mingyang
PMID:	29437869

58.
Journal:	J Cancer. 2018 Jan 1;9(2):239-249.
Title:	Early and Partial Reduction in CD4(+)Foxp3(+) Regulatory T Cells during Colitis-Associated Colon Cancer Induces CD4(+) and CD8(+) T Cell Activation Inhibiting Tumorigenesis.
Author:	Olguin, Jonadab E\|Medina-Andrade, Itzel\|Molina, Emmanuel\|Vazquez, Armando\|Pacheco-Fernandez, Thalia\|Saavedra, Rafael\|Perez-Plasencia, Carlos\|Chirino, Yolanda I\|Vaca-Paniagua, Felipe\|Arias-Romero, Luis E\|Gutierrez-Cirlos, Emma B\|Leon-Cabrera, Sonia A\|Rodri
PMID:	29344269

59.
Journal:	Oncoimmunology. 2017 Nov 6;7(2):e1390640.
Title:	High numbers of PDCD1 (PD-1)-positive T cells and B2M mutations in microsatellite-unstable colorectal cancer.
Author:	Janikovits, Jonas\|Muller, Meike\|Krzykalla, Julia\|Korner, Sandrina\|Echterdiek, Fabian\|Lahrmann, Bernd\|Grabe, Niels\|Schneider, Martin\|Benner, Axel\|Doeberitz, Magnus von Knebel\|Kloor, Matthias
PMID:	29308317